Results 311 to 320 of about 2,058,358 (352)

Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fraction. [PDF]

Int J Cardiol Heart Vasc
Achten A, Weerts J, van Koll J, Ghossein M, Mourmans SGJ, Aizpurua AB, van Stipdonk AMW, Vernooy K, Prinzen FW, Rocca HB, Knackstedt C, van Empel VPM.   +11 more
europepmc   +1 more source

Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta‐analysis

European Journal of Heart Failure, EarlyView.
Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta‐analysis. Clonal haematopoiesis and heart failure: a meta‐analysis. CH, clonal haematopoiesis; CI, confidence interval; HF, heart failure. [Correction added on 15 March 2025, after first online publication: The graphical image was corrected in ...
Paschalis Karakasis, Eleftheria Lefkou, Konstantinos Pamporis, Dimitrios Farmakis, Dimitrios Patoulias, Antonios P. Antoniadis, Stephane Heymans, Gerasimos Filippatos, Nikolaos Fragakis   +8 more
wiley   +1 more source

The sympathetic nervous system in heart failure with preserved ejection fraction. [PDF]

Heart Fail Rev
Chang JW, Ramchandra R.
europepmc   +1 more source

Cardiac rhythm devices in heart failure with reduced ejection fraction – role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document

European Journal of Heart Failure, EarlyView.
Abstract Guidelines for management of heart failure with reduced ejection fraction (HFrEF) emphasize personalized care, patient engagement, and shared decision‐making. Medications and cardiac rhythm management (CRM) devices are recommended with a high level of evidence. However, there are significant disparities: patients who could benefit from devices
Biykem Bozkurt, Wilfried Mullens, Christophe Leclercq, Andrea M. Russo, Gianluigi Savarese, Michael Böhm, Loreena Hill, Koichiro Kinugawa, Naoki Sato, William T. Abraham, Antoni Bayes‐Genis, Alexandre Mebazaa, Giuseppe M.C. Rosano, Shelley Zieroth, Cecilia Linde, Javed Butler   +15 more
wiley   +1 more source

Key Mechanisms of Oxidative Stress-Induced Ferroptosis in Heart Failure with Preserved Ejection Fraction and Potential Therapeutic Approaches. [PDF]

Rev Cardiovasc Med
Lin J, Li B, Guo X, Li G, Zhang Q, Wang W.   +5 more
europepmc   +1 more source

How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC

European Journal of Heart Failure, EarlyView.
Linking guideline‐directed medical therapy (GDMT) implementation and appropriate polypharmacy management in heart failure (HF). Polypharmacy can represent a barrier to the proper implementation of life‐prolonging GDMT for HF. A reasonable balance between the optimization of GDMT and avoiding inappropriate polypharmacy is mandatory in the contemporary ...
Davide Stolfo, Massimo Iacoviello, Ovidiu Chioncel, Markus S. Anker, Antoni Bayes‐Genis, Frieder Braunschweig, Antonio Cannata, Seif El Hadidi, Gerasimos Filippatos, Pardeep Jhund, Alexandre Mebazaa, Brenda Moura, Massimo Piepoli, Robin Ray, Arsen D. Ristic, Petar Seferovic, Maggie Simpson, Hadi Skouri, Carlo Gabriele Tocchetti, Sophie Van Linthout, Cristiana Vitale, Maurizio Volterrani, Kalliopi Keramida, Sven Wassmann, Basil S. Lewis, Marco Metra, Giuseppe M.C. Rosano, Gianluigi Savarese   +27 more
wiley   +1 more source

Lean ZSF1 rats in basic research on heart failure with preserved ejection fraction. [PDF]

ESC Heart Fail
Büttner P, Augstein A, Abdellatif M, Lourenço A, Leite-Moreira A, Falcão-Pires I, Werner S, Thiele H, Sedej S, Schauer A, Adams V.   +10 more
europepmc   +1 more source

Tricuspid regurgitation risk scores in patients undergoing tricuspid valve transcatheter edge‐to‐edge repair

European Journal of Heart Failure, EarlyView.
Cecilia Ennin, Lukas Stolz, Thomas J. Stocker, Ludwig T. Weckbach, Philipp M. Doldi, Julia Novotny, Jonas Gmeiner, Michael Näbauer, Steffen Massberg, Jörg Hausleiter   +9 more
wiley   +1 more source

Cardioprotective effects of semaglutide on isolated human ventricular myocardium

European Journal of Heart Failure, EarlyView.
Semaglutide reduces late sodium current (INa) and diastolic calcium (Ca) sparks in human cardiomyocytes from aortic stenosis (AS) and end‐stage heart failure with reduced ejection fraction (HFrEF) patients, thereby increasing Ca transients. Improved Ca storage may underly the enhanced contractility of human cardiomyocytes upon semaglutide.
Thomas Krammer, Maria J. Baier, Philipp Hegner, Tilman Zschiedrich, David Lukas, Matthias Wolf, Christian Le Phu, Vanessa Lutz, Katja Evert, Kostiantyn Kozakov, Jing Li, Andreas Holzamer, Lars S. Maier, Zdenek Provaznik, Donald M. Bers, Stefan Wagner, Julian Mustroph   +16 more
wiley   +1 more source

Growth differentiation factor-15 and N-terminal pro-BNP in acute heart failure with preserved ejection fraction. [PDF]

ESC Heart Fail
Otaki Y, Watanabe T, Shimizu M, Tachibana S, Sato J, Kobayashi Y, Tamura H, Kato S, Nishiyama S, Takahashi H, Arimoto T, Watanabe M.   +11 more
europepmc   +1 more source